FDA to review whether to allow more access to certain peptides

The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized ...

Vitamin recall update as FDA sets risk level

Certain people "run the risk of a serious or life-threatening allergic reaction if they consume this product," the firm ...

Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats up

By Manya Saini April 17 (Reuters) - Weight-loss drug developer Kailera Therapeutics' shares surged 62.5% in their Nasdaq ...

Woburn biotech to lay off more than 200 after second FDA rejection of skin cancer treatment

In a notification the state received from Replimune on Monday, the Woburn-based company said it was laying off 63 employees, ...

Women can't get estrogen patches. Here's what the FDA is doing to help.

Estrogen patches, one of the most popular menopause treatments, have been in short supply this year. Now the FDA is working ...

FDA will consider easing restrictions on peptides as RFK Jr. calls himself a "big fan"

The FDA meeting announcement​ follows repeated pledges by Health Secretary Robert F. Kennedy Jr. to loosen regulations on ...

FACT FOCUS: Trump says drug trafficking by sea is down 98.2%. The numbers don’t show that

President Donald Trump has repeatedly claimed that the flow of drugs into the U.S. by sea has been nearly eradicated under ...

FDA asks drug manufacturer for more safety data on Foundayo GLP-1

The U.S. Food and Drug Administration is asking Eli Lilly and Company, the leading manufacturer of GLP-1s, for additional ...
mlive

Multi-county drug bust yields nearly 700 grams of heroin, fentanyl and $274K in assets

Detectives with the Livingston and Washtenaw Narcotics Enforcement Team executed five search warrants April 17 at residences ...

‘An attempt to look reasonable.’ Fmr. FDA official on RFK Jr’s shifting messaging on vaccines

What do America’s health officials think of the HHS Secretary’s shifts in messaging about vaccines and measles? CNN News Central’s Kate Bolduan asks Dr. Paul Offit, a former member of the FDA’s ...
Fierce Pharma

FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER

The FDA should strengthen the evidence required for the approval of drugs under its accelerated pathway and increase the ...